Shanghai Jiahui International Hospital
Shanghai's first government-authorized international tertiary hospital, opened in October 2017 in long-term strategic partnership with Massachusetts General Hospital (Harvard Medical School affiliate), offering JCI-accredited integrated cancer care through the Jiahui International Cancer Center with weekly joint tumor boards with the MGH Cancer Center and a multilingual, foreign-staffed clinical team designed for international patients.
About Shanghai Jiahui International Hospital
Shanghai Jiahui International Hospital is the first government-authorized foreign-funded tertiary international general hospital in Shanghai. It was approved by China's Ministry of Health and the Shanghai Municipal Government in April 2011, broke ground in September 2014, and opened to the public in October 2017. The hospital is the flagship of Jiahui Health, an integrated healthcare network established in 2009 and headquartered in Shanghai, which now operates clinics and wellness centres across Shanghai (Xuhui, Yangpu, Jing'an), Suzhou, Hangzhou, Shenzhen Futian, Kunshan and Hong Kong. The 500-bed facility on Guiping Road in Xuhui District was designed by NBBJ, the same architectural firm behind Massachusetts General Hospital and Cleveland Clinic, and became the first healthcare institute in mainland China to receive LEED Gold for Healthcare certification.
Jiahui International Hospital maintains a long-term strategic clinical collaboration with Massachusetts General Hospital (MGH), a founding member of Harvard Medical School and one of the highest-ranked hospitals in the United States. The partnership formally began in 2011 as a consulting relationship, became a Memorandum of Understanding in 2014, and was deepened in December 2016 with a long-term agreement covering overall hospital planning, operations management, clinical protocols, medical training and joint clinical research. The Jiahui International Cancer Center (JICC) holds weekly International Tumor Board meetings with the MGH Cancer Center, receives International Radiation Oncology Treatment Plan Peer Review from MGH faculty, and operates under shared cancer care policies, treatment protocols and quality and safety programs designed jointly with MGH. The hospital's medical team includes approximately 150 physicians and 1,000 healthcare professionals from 13 countries, with over 25% of physicians internationally trained and several holding joint appointments with MGH, delivering services in more than 15 languages.
Jiahui International Hospital operates more than 35 medical specialties organised around four Centers of Excellence: the Jiahui International Cancer Center (JICC), the Women and Children's Health Center, the Orthopedics and Sports Medicine Center, and the Cardiac Center, together with Family Medicine, General Surgery, and 24-hour Emergency Care. The cancer centre provides comprehensive multidisciplinary care including surgical, medical and radiation oncology with a Varian TrueBeam linear accelerator, supported by molecular diagnostics, targeted therapy, immunotherapy and chemotherapy. A dedicated CancerHub staffed by oncology nurse navigators coordinates appointments and family support, and most patients complete their full diagnostic workup within two to three days of arrival followed by a multidisciplinary treatment discussion. The hospital is also Jiahui Health's lead site for follow-up care of patients who have received treatment at MGH and other leading US institutions, with structured teleconferencing for remote MGH specialist consultations. Jiahui exclusively publishes the Chinese-language edition of the New England Journal of Medicine (NEJM YiXueQianYan), reflecting its academic positioning.
CancerFax works with international and Indian families considering Jiahui International Hospital alongside other top cancer centres in China and globally. We help patients understand whether Jiahui is the right clinical and financial fit for their specific diagnosis, particularly for those who want an internationally accredited, MGH-aligned care experience in Shanghai without travelling to the United States. Our coordination service covers preliminary case review and second-opinion submission to the Jiahui International Cancer Center, Chinese visa support documentation, comparative cost estimates against other top centres including Sun Yat-sen University Cancer Center, Fudan University Shanghai Cancer Center and international hospitals in India, Korea and the UAE, accredited translation of foreign-language records, accommodation guidance near the Xuhui District campus, and where helpful, advice on combining a Jiahui consultation with a more specialised consultation at a Chinese public cancer centre. CancerFax charges patients nothing for this coordination, and we will tell you openly if a different hospital would serve your specific case more appropriately.
| Hospital at a Glance | |
|---|---|
| Country | China |
| City | Shanghai (Xuhui District) |
| Established | Jiahui Health 2009 · Hospital opened October 2017 |
| Hospital Type | Foreign-funded Tertiary International General Hospital (first of its kind in Shanghai) · Flagship of Jiahui Health Network |
| Accreditation | JCI-Accredited · Approved by China's National Health and Family Planning Commission · First healthcare institute in mainland China with LEED Gold for Healthcare · Designated medical institution for China International Import Expo (CIIE) |
| Beds | 500 licensed tertiary beds |
| Annual Patient Activity | Approximately 150 physicians and 1,000+ healthcare professionals from 13 countries; multilingual services in 15+ languages; over 25% of physicians internationally trained, several with joint MGH appointments |
| Research Focus | Integrated oncology with MGH joint tumor boards, women's health, breast cancer, gastrointestinal and hepatobiliary oncology, precision medicine, NEJM-affiliated clinical content |
Why Patients Choose Shanghai Jiahui International Hospital
Jiahui International Hospital was purpose-built for international patients seeking Massachusetts General Hospital-aligned, JCI-accredited care in Shanghai, combining a multilingual foreign-staffed clinical team, joint MGH tumor boards, integrated Centers of Excellence and a direct billing network with major international insurance providers.
Cancer Specialties and Clinical Departments
The Jiahui International Cancer Center (JICC) provides multidisciplinary cancer care across the major solid tumour groups, supported by the wider hospital's four Centers of Excellence and 35-plus medical specialties.
Advanced Treatment Capabilities
Key Specialists at Shanghai Jiahui International Hospital
Jiahui Health was founded by CEO Ge Feng, a former investment banker who envisioned a new model of healthcare in China focused on continuity of care, patient experience and international standards. The Shanghai Jiahui International Hospital was led at opening by President David Cook (previously of Mayo Clinic) and Chief Medical Officer Dr. John Hsiang (previously Director of Neurosurgery at Swedish Medical Center), who now serves as Chairman of the Jiahui Health Executive Committee. The Jiahui International Cancer Center has been led by Dr. Andrew Zhu, a special consultant recruited from the MGH Cancer Center who previously led a division of medical oncology and hematology and is internationally recognised for expertise in liver and bile duct cancers. Approximately 25% of Jiahui's physicians are from overseas, and several senior physicians hold joint appointments with MGH.
Other senior clinical leaders include Dr. Tibor Kovacs, former President of the European Society of Surgical Oncology (ESSO) and Director of the Breast Health Program at Jiahui, who leads breast cancer care; Dr. Li Jun, Chief of Surgery, whose team performs complex oncological surgery across subspecialties; Dr. Xuan Linli, Chief of Medical Oncology; Dr. Zhao Jianfei, Deputy Editor of NEJM's Chinese edition; and Dr. Alexander Lin, Chief of Obstetrics and Gynecology and Director of Women's Health, a US-trained OB-GYN with over two decades of practice in Chicago before joining Jiahui in 2018. Patients seeking a specific physician consultation or a focused multidisciplinary second opinion can submit their request through CancerFax. We work with Jiahui's International Patient Services office to match each case to the appropriate department and care team before any travel is committed, and will tell you openly if a different cancer centre would serve your case more appropriately.
Patients seeking specific physician consultations or second opinions may request a review through the CancerFax coordination process before confirming travel or admission.
Clinical Infrastructure and Treatment Technology
Jiahui International Hospital's NBBJ-designed Xuhui District campus combines a 500-bed tertiary hospital environment built to LEED Gold for Healthcare and JCI standards with a Varian TrueBeam radiotherapy platform, modern surgical theatres, precision diagnostic capabilities and MGH-aligned clinical protocols.
- Varian TrueBeam linear accelerator for image-guided radiotherapy (IGRT), stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT)
- Diagnostic imaging including MRI, CT, PET-CT, ultrasound and mammography
- International Radiation Oncology Treatment Plan Peer Review by MGH Cancer Center faculty
- Comprehensive medical oncology providing chemotherapy, targeted therapy and immunotherapy under joint clinical protocols developed with the MGH Cancer Center
- Dedicated CancerHub with oncology nurse navigators for appointment coordination and family support
- Weekly International Tumor Board meetings with MGH Cancer Center for multidisciplinary review of complex cases
- Modern operating theatres for general, gastrointestinal, hepatobiliary, breast, thoracic, urologic and gynecologic cancer surgery
- Minimally invasive laparoscopic and endoscopic surgical platforms
- Recent collaborations with Japan's Cancer Institute Hospital on minimally invasive surgical techniques and precision oncology
- Molecular diagnostics, next-generation sequencing and liquid biopsy through partner laboratory Genomicare Bio
- Comprehensive pathology, hematology and biochemistry laboratory services
- NEJM YiXueQianYan (Chinese edition of New England Journal of Medicine) co-published by Jiahui, supporting evidence-based clinical practice
International Patient Support at Shanghai Jiahui International Hospital
Jiahui International Hospital was purpose-built for international patients, with multilingual clinical staff from 13 countries, services in more than 15 languages, an established direct billing network with major international insurance providers, and a dedicated International Patient Services office. The hospital is the only non-public medical institution selected as a designated medical care provider for the annual China International Import Expo.
What to Prepare Before Traveling
- arrow_rightShare complete pathology reports, biopsy slides where requested for re-review, recent CT, PET-CT and MRI imaging, molecular profiling, prior treatment summaries and a current medication list (in English or Chinese) with the Jiahui International Patient Services office at least one to two weeks before your planned consultation. Most patients complete their full diagnostic workup at Jiahui within two to three days of arrival.
- arrow_rightApply for an appropriate Chinese visa (L for short-term tourist, M for business or medical). Jiahui International Hospital can issue an official invitation letter for the patient and accompanying family members; many south and southeast Asian countries also have e-visa or visa-on-arrival options for shorter stays in mainland China.
- arrow_rightPlan travel via Shanghai Pudong International Airport (PVG) or Shanghai Hongqiao International Airport (SHA); both are well connected to most major Asian, European and Middle Eastern cities. Allow for a stay of at least two to three weeks for initial evaluation, treatment planning and the start of treatment.
Jiahui International Hospital can be contacted directly through its International Patient Services office at [email protected], by 24-hour appointment hotline 400 868 3000 (in mainland China), or through CancerFax, which coordinates all submissions, translation, visa and travel arrangements on the patient's behalf, manages comparison with other cancer hospitals where useful, and remains the single point of contact through treatment and follow-up at no cost to the patient.
Patient Facilities and Accommodation at Shanghai Jiahui International Hospital
Jiahui International Hospital's NBBJ-designed Xuhui District campus combines hotel-style finishes with LEED Gold for Healthcare certified construction, offering a calm, low-volume international hospital environment with private suites, multilingual coordination and comprehensive on-campus support services.
Family members accompanying international patients can be accommodated in private suites alongside the patient, or at nearby Xuhui District hotels within a short taxi or metro ride of the hospital. The International Patient Services office can advise on extended-stay arrangements for longer treatment journeys, and CancerFax can help plan budget-conscious options for families on extended trips.
How to Reach Shanghai Jiahui International Hospital
Shanghai Jiahui International Hospital is located on Guiping Road in Xuhui District of Shanghai, in the southwestern part of central Shanghai close to the Caohejing Hi-Tech Park, well connected by metro and expressway to both of Shanghai's international airports.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Shanghai Jiahui International Hospital — Patient Questions Answered
CancerFax acts as your single coordinator for the entire Jiahui International Hospital journey. You begin by sharing your medical records, including pathology reports, biopsy slides where available, recent imaging, molecular profiling and prior treatment summaries through our secure intake. Our clinical team reviews your case, identifies whether Jiahui's MGH-aligned model is genuinely the best fit for your specific diagnosis, and where useful compares it with other top cancer centres in China and internationally. We then submit your case to Jiahui's International Patient Services office, who arrange your consultation, multidisciplinary review or remote second opinion.
Once your consultation is confirmed, CancerFax prepares your full pre-travel pack: Jiahui's official cost estimate (shared with you without any CancerFax mark-up), Chinese visa documentation, accredited translation of your home-country reports into Chinese or English as needed, accommodation guidance in the Xuhui District near the campus, and where relevant a check against your international insurance provider (Jiahui has direct billing arrangements with most major international insurance companies). We remain your single point of contact through admission, treatment and follow-up, and we will tell you honestly if a different cancer hospital would serve your specific case better. There is no fee to the patient for any of this coordination.
The Jiahui International Cancer Center (JICC) provides comprehensive cancer care across solid tumours, with particular depth in gastrointestinal and hepatobiliary cancers (liver, bile duct, gastric, colorectal), breast cancer, women's cancers (cervical, ovarian, endometrial), urologic cancers and thoracic oncology. The cancer centre is led by faculty with senior international experience including a former MGH Cancer Center medical oncologist with a specialty in liver and bile duct cancers, and a former President of the European Society of Surgical Oncology leading breast cancer care. Jiahui is particularly well-suited for patients who want an internationally accredited, English-supported, MGH-aligned cancer care experience without travelling to the United States. For very specialised cases such as relapsed haematologic malignancies, large-scale early-phase clinical trial portfolios or rare and refractory cancers requiring deep public-hospital infrastructure, CancerFax may also discuss alternative options at Sun Yat-sen University Cancer Center, Fudan University Shanghai Cancer Center, Lu Daopei Hospital or other leading Chinese cancer centres alongside the Jiahui pathway.
Yes. The Jiahui International Cancer Center holds weekly International Tumor Board meetings with Massachusetts General Hospital Cancer Center faculty, where complex cases are reviewed jointly by Jiahui and MGH oncologists, surgeons, radiation oncologists and pathologists. The radiation oncology programme receives International Radiation Oncology Treatment Plan Peer Review from MGH faculty, and the hospital operates a Varian TrueBeam linear accelerator. Jiahui's medical oncology team provides chemotherapy, targeted therapy and immunotherapy under joint clinical protocols developed with MGH. Precision oncology is supported by partner laboratory Genomicare Bio for next-generation sequencing and liquid biopsy. Jiahui does not currently offer some highly specialised advanced therapies such as commercial CAR T-cell therapy or proton beam radiotherapy on-site. If your treatment plan calls for those modalities, CancerFax can guide you to other Chinese cancer hospitals where they are routinely delivered, including Lu Daopei Hospital in Beijing for CAR T-cell therapy.
Yes. The Jiahui International Cancer Center provides remote second-opinion consultations based on your medical records before any travel commitment. Through Jiahui's teleconferencing platform, eligible patients can also have a remote consultation with an MGH specialist for additional review of complex cases. CancerFax facilitates submission of your records, coordinates accredited translation into Chinese or English, follows up on your behalf and helps you understand the resulting opinion, including how it compares with treatment plans from other top cancer centres. A remote opinion is often the most efficient first step for patients from South Asia, Southeast Asia, the Middle East and Africa who would otherwise need to travel before knowing whether Jiahui is the right clinical fit.
Treatment at Jiahui International Hospital is significantly more expensive than at top Chinese public cancer hospitals such as Sun Yat-sen University Cancer Center or Fudan University Shanghai Cancer Center, reflecting Jiahui's international hospital pricing structure, smaller patient volumes, English-language clinical environment and dedicated international patient services. At the same time, Jiahui treatment is substantially less expensive than comparable JCI-accredited international hospital care in the United States, Western Europe or Singapore, often by a factor of three to five for complex cancer care. Jiahui has direct billing arrangements with most major international insurance providers, which simplifies payment for insured international patients. CancerFax shares Jiahui's official cost estimates with you at no extra charge and without any CancerFax mark-up, and we are happy to compare them openly with other cancer hospitals in China and internationally before any decision is made.
Send Your Medical Reports to Shanghai Jiahui International Hospital via CancerFax
CancerFax reviews your records, identifies whether Jiahui's MGH-aligned international oncology model is genuinely appropriate for your case, and coordinates your consultation or remote second opinion in Shanghai, at no cost, with no obligation, and with full medical confidentiality throughout.